Inactive Instrument

All News PCI Biotech Oslo Bors

Equities

Minutes of Annual General Meeting 2024	05-24	GL
PCI Biotech : Notice AGM 2024	05-03	PU
PCI Biotech : Proposed resolutions for the AGM 2024	05-03	PU
PCI Biotech Holding ASA - Notice of Annual General Meeting 2024	05-03	GL
PCI Biotech : Annual Report 2023	05-02	PU
PCI Biotech Holding ASA - Annual Report 2023	04-26	GL
PCI Biotech Holding ASA Reports Earnings Results for the Full Year Ended December 31, 2023	02-14	CI
PCI Biotech second half 2023 interim results	02-14	GL
PCI Biotech second half 2023 interim results	02-14	AQ
PCI Biotech: Invitation to second half interim 2023 results presentation	02-12	GL
PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing	23-10-13	GL
Pci Biotech Initiates Field Testing of Its Proprietary Technology for Gene Therapy Manufacturing	23-10-13	CI
PCI Biotech: European patent for mRNA delivery with fimaNAc	23-09-07	GL
PCI Biotech Holding ASA Announces European Patent Office Intends to Grant A New Patent Covering Delivery of mRNA	23-09-07	CI
PCI Biotech: Employee share option scheme	23-09-04	GL
PCI Biotech: Employee share option scheme	23-09-04	AQ
PCI Biotech: Write-down of share capital registered	23-09-01	GL
Financial calendar	23-08-31	AQ
PCI Biotech Holding ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-31	CI
PCI Biotech first half 2023 interim results	23-08-31	GL

No results for this search